# 119-hr-4780: USTRx Act

119-hr-4780, USTRx Act, is a 119th Congress bill sponsored by Rep. Arrington, Jodey C. [R-TX-19] (R-TX); status introduced (as of 2026-09-21).

- Canonical: https://policyrisk.com/legislation/119-hr-4780
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-4780
- Congress: 119
- Title: USTRx Act
- Status: introduced
- Introduced: 2025-07-29
- Sponsor: Rep. Arrington, Jodey C. [R-TX-19] (R-TX)
- Cosponsors: 8
- Policy area: Foreign Trade and International Finance
- Touches household money: no
- Last recorded action: 2026-09-21

## Summary

**This bill would create a new federal trade role to use trade tools to press high-income countries to change drug pricing and market access.** It is framed to defend U.S. pharmaceutical innovation and to push foreign reimbursement systems to be more transparent, fair, and market-based. - Patients and families: The bill argues that foreign price controls shift the cost of drug innovation onto U.S. patients and taxpayers and seeks to protect access to innovative treatments by pressuring other countries to recognize drug value. - U.S. pharmaceutical manufacturers: It would establish a Chief Pharmaceutical Trade Negotiator to negotiate and enforce trade rules, coordinate on intellectual property issues, and pursue actions when high-income countries limit U.S. market access. - Government and trade officials: Requires an annual report naming high-income countries using World Bank classifications, assessing their pharmaceutical pricing and market rules, and a 30-day plan to respond to adverse findings that can include investigations under the Trade Act.

## Cosponsors (8)

- Rep. Buchanan, Vern [R-FL-16] (R-FL), 2025-07-29T00:00:00.000Z
- Rep. Fleischmann, Charles J. "Chuck" [R-TN-3] (R-TN), 2025-07-29T00:00:00.000Z
- Rep. Tenney, Claudia [R-NY-24] (R-NY), 2025-07-29T00:00:00.000Z
- Rep. Murphy, Gregory F. [R-NC-3] (R-NC), 2025-07-29T00:00:00.000Z
- Rep. Miller, Carol D. [R-WV-1] (R-WV), 2025-08-05T00:00:00.000Z
- Rep. Baird, James R. [R-IN-4] (R-IN), 2026-03-27T00:00:00.000Z
- Rep. Moran, Nathaniel [R-TX-1] (R-TX), 2026-04-20T00:00:00.000Z
- Rep. Steube, W. Gregory [R-FL-17] (R-FL), 2026-07-21T00:00:00.000Z

## Provisions PRIA read

- New negotiator for U.S. drug makers: benefit, low. This bill would create a Chief Pharmaceutical Trade Negotiator at the U.S. Trade Representative. The Chief would negotiate and enforce trade rules for U.S. drug makers. The Chief would act against high-income countries whose policies block fair market access. The Chief would also advocate for U.S.…
- Yearly review of foreign drug pricing: mixed, medium. This bill would require USTR to make a yearly list of high-income countries using World Bank data. Each year, USTR would report on each country’s drug pricing and trade rules for the prior fiscal year. The report would go to House Ways and Means and Senate Finance and be posted online. If USTR find…

## Related bills

- 119-hr-1: One Big Beautiful Bill Act
- 119-hr-1301: Death Tax Repeal Act
- 119-hr-703: Main Street Tax Certainty Act
- 119-hr-425: Repealing Big Brother Overreach Act
- 119-hr-38: Constitutional Concealed Carry Reciprocity Act of 2025
- 119-hr-1628: 761st Tank Battalion Congressional Gold Medal Act

## Sources
- [119-hr-4780 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/4780)

## Related
- [119-hr-1: One Big Beautiful Bill Act](https://policyrisk.com/legislation/119-hr-1)
- [119-hr-1301: Death Tax Repeal Act](https://policyrisk.com/legislation/119-hr-1301)
- [119-hr-703: Main Street Tax Certainty Act](https://policyrisk.com/legislation/119-hr-703)
- [119-hr-425: Repealing Big Brother Overreach Act](https://policyrisk.com/legislation/119-hr-425)
- [119-hr-38: Constitutional Concealed Carry Reciprocity Act of 2025](https://policyrisk.com/legislation/119-hr-38)
- [119-hr-1628: 761st Tank Battalion Congressional Gold Medal Act](https://policyrisk.com/legislation/119-hr-1628)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-4780 (as of 2026-09-21).